PharmaCyte Biotech, Inc. (PMCB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 9.09M |
| Enterprise Value | -6.08M |
| P/E Ratio | -0.74 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.18 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 1.16 |
| Fiscal Year | April 30, 2025 |
| Most Recent Quarter | January 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.06 |
| Return On Equity | -0.08 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 30.66M |
| Net Income | 30.66M |
| Diluted EPS | 3.19 |
| Total Cash | 20.54M |
| Total Cash/Share | 2.22 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 12.33 |
| Book Value Per Share | 4.25 |
| 52-Week Change | -27.54 |
| 52-Week High | 1.51 |
| 52-Week Low | 0.63 |
| Moving Average 50 Days | 0.76 |
| Moving Average 200 Days | 0.83 |
| Average Volume | 197,070 |
| Shares Outstanding | 6.8M |
| % Held by Institutions | 10.44 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.05 |
| Last Split Factor | 1:1550 |
| Last Split Date | July 12, 2021 |